Evaluating drug prevention in the European Union: papers arising from the First European Conference on the Evaluation of Drug Prevention held in Lisbon, Portugal, 12 - 14 march 1997

Preventing drug use is a universal challenge and identifying approaches that work, and why they work, is a specific objective for drug professionals and evaluators. This monograph focuses on the ideology of prevention in Europe. In particular, it presents arguments for making evaluation a routine an...

Ausführliche Beschreibung

Gespeichert in:  
Bibliographische Detailangaben
Körperschaften: Europäische Kommission, Beobachtungsstelle für Drogen und Drogensucht (Herausgebendes Organ) ; European Conference on the Evaluation of Drug Prevention 1 1997, Lissabon (GeistigeR SchöpferIn)
Beteiligte: Baker, Oswin (HerausgeberIn) ; Europäische Kommission Beobachtungsstelle für Drogen und Drogensucht ; European Conference on the Evaluation of Drug Prevention
Medienart: Elektronisch Buch
Sprache:Englisch
Veröffentlicht: Luxemburg Office for Official Publications of the European Communities 1998
In: EMCDDA scientific monograph series (2)
Jahr: 1998
Online Zugang: Volltext (kostenfrei)
Volltext (kostenfrei)
Volltext (kostenfrei)
Verfügbarkeit prüfen: HBZ Gateway
Schlagwörter:
Ähnliche Datensätze:Erscheint auch als: 1630815349
Beschreibung
Zusammenfassung:Preventing drug use is a universal challenge and identifying approaches that work, and why they work, is a specific objective for drug professionals and evaluators. This monograph focuses on the ideology of prevention in Europe. In particular, it presents arguments for making evaluation a routine and scientifically sound procedure that draws on good practice and proven methodology. The volume includes a broad overview of the history and status of prevention activities and their evaluation in Europe and the US, as well as an introduction to the theoretical foundations of evaluation. Also reviewed are the most commonly encountered evaluation methods, instruments, problems and obstacles and the diversity and complexity of evaluation models. The monograph explores how drug professionals can interest politicians in evaluation and how evaluation can stimulate the allocation of funds.
Beschreibung:1 Online-Ressource (139 Seiten)
DOI:10.15496/publikation-23194